RenovoRx, a United States-based company focused on targeted cancer therapy, has been honoured in the Drug Delivery Technology category at the Fierce Innovation Awards - Life Sciences Edition 2020 from the publisher of Fierce Biotech and Fierce Pharma, it was reported on Tuesday.

The award recognises firms showcasing innovative solutions, technologies, and services that make an impact to biotech and pharma companies. The company was honoured for its Trans-Arterial Micro-Perfusion technology, a unique method for targeted delivery of chemotherapy in the treatment of solid tumours.

A panel of executives from major biotech and pharma companies reviewed the applications for the award programme. The applications were assessed based on the criteria of effectiveness, technical innovation, competitive advantage, financial impact, and true innovation.